Early-Onset Colorectal Cancer Patients Too Young for Screening

Last updated: April 27, 2026
Sponsor: Methodist Health System
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colorectal Cancer

Colon Cancer; Rectal Cancer

Rectal Cancer

Treatment

Colorectal cancer

Clinical Study ID

NCT07559825
036.HBP.2020.R
  • Ages > 35
  • All Genders

Study Summary

This is a population-based retrospective study using the Surveillance, Epidemiology, and End Results (SEER) registry and National Cancer Data Base (NCDB) to look at colorectal cancer (CRC) patients younger than 35 and comparing them against CRC patients older than 35 years of age.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Colorectal cancer

Exclusion

Exclusion Criteria:

  • No Colorectal cancer

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Colorectal cancer
Phase:
Study Start date:
January 31, 2020
Estimated Completion Date:
January 31, 2028

Study Description

Specifically, investigator want to investigate the effect of having a diagnosis of CRC before the age of 35 years on:disease stage at presentation, insurance status at diagnosis, treatment patterns by stage, and adjusted cancer-specific survival. The hypothesis is that patients younger than 35 years of age with CRC will present with more advanced disease at diagnosis but will have longer survival overall through more aggressive therapy.

Connect with a study center

  • Methodist Dallas Medical Center- Clinical Research Institute

    Dallas, Texas 75203
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.